checkAd

     153  0 Kommentare Black Diamond Therapeutics Announces the Appointment of Rachel Humphrey, M.D., as Chief Medical Officer - Seite 3

    Contacts:

    For Investors:
    Natalie Wildenradt
    investors@bdtherapeutics.com

    Lesen Sie auch

    For Media:
    Kathy Vincent
    (310) 403-8951
    media@bdtherapeutics.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Black Diamond Therapeutics Announces the Appointment of Rachel Humphrey, M.D., as Chief Medical Officer - Seite 3 Dr. Humphrey brings more than 20 years of experience as a leader in oncology drug developmentCAMBRIDGE, Mass. and NEW YORK, Sept. 08, 2020 (GLOBE NEWSWIRE) - Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company …